Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Pankreas
»
Neoplasms
15. April 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Esophagus
Pankreas
Neoplasms
Pancreatitis
Others
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2986
Articles 1 - 20 / 59705
The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [(177)Lu]Lu-DOTA-TATE: A post-authorisation safety study.
J Neuroendocrinol
Hofland J, Grana CM, Weickert MO, Moore AR, Shah T, Prakash V, Kolasi, de Herder WW, Spada F, Xu L, Fite R, Wu Y, .
PMID: 41978231 [PubMed - indexed for MEDLINE]
High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma.
Int J Mol Sci
Prouse T, Majumder R, Majumder S.
PMID: 41977152 [PubMed - indexed for MEDLINE]
Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer.
Cancers (Basel)
Kashima H, Kawai M, Iimori K, Nagao M, Morikawa TJ, Otomo R, Hirai M, Minaga K, Asada M, Umemura A, Uenoyama Y, Morita T, Yazumi S, Minami R, Marui S, Yamauchi Y, Nakai Y, Takada Y, Shio S, Yoshioka T, Kanda N, Masuda T, Nagai K, Hatano E, Fukuda A, Seno H.
PMID: 41976399 [PubMed]
Systematic Review and Meta-Analysis of Current and Novel Approaches in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer.
Cancers (Basel)
Le K, Le KDR, Hong W, Gibbs P, Yoshino O, Lee B.
PMID: 41976359 [PubMed]
Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.
Cancers (Basel)
Zhang J, Geng M, Friess H, Demir IE, Scheufele F.
PMID: 41976353 [PubMed]
Cardiovascular Risk in Pancreatic Cancer: A Meta-Analysis of 197 Studies.
Cancers (Basel)
Németh J, Lee J, Eperjesi O, Gagyi EB, Bánfalvi Z, Lillik V, Creanga-Murariu I, Tóth R, Szalai EÁ, Obeidat M, Váncsa S, Bunduc S, Hegyi P.
PMID: 41976330 [PubMed]
Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights.
Cancers (Basel)
Yokoyama Y, Morimoto Y, Yamamoto H, Kouda S, Kawanami S, Yang R, Zhang Y, Tsujimoto M, Nagata N, Shimomura Y, Nishida K, Hata T, Inoue A, Shibata S, Yamamoto H, Mori M.
PMID: 41976327 [PubMed]
Pathogenesis, Diagnostic Pathways, and New Therapeutic and Nutritional Strategies for Pancreatic Cancer-Associated Cachexia.
Cancers (Basel)
Klus W, Ossowska J, Kowalcze K, Kiliszczyk A, Paziewska A.
PMID: 41976282 [PubMed]
EGFR ligand Angiogenin predicts response to ALK5 inhibition in pancreatic cancer via a TNF-α paracrine axis in tumor-associated macrophages.
Oncogene
Pietrobono S, De Vita V, Mangiameli D, Aparo A, Lorenzo ES, Bonato A, Bertolini M, Scarlato E, Casalino S, Quinzii A, Zecchetto C, Melisi D.
PMID: 41975075 [PubMed - as supplied by publisher]
Human endogenous retroviruses in liver cancer: a double-edged sword in tumor progression and anti-tumor immunity.
Crit Rev Oncol Hematol
Jiang X, Huang Z, Zhong Y, Lv W, Zhou R, Wang J, Liu J.
PMID: 41974391 [PubMed - as supplied by publisher]
Towards transparent and interpretable screening: multi-biofluid FTIR spectroscopy with LLM-Augmented explainability for pancreatic cancer detection.
Methods
Tang Z, Irvine O, Duckworth E, Costanzo C, Lillis K, Ren J, Anupama Bandaranayake PM, Sarireh BA, Mortimer M, Kanamarlapudi V, Higginbotham V, Chandrashekhara SH, Mora B, Roy D.
PMID: 41974239 [PubMed - as supplied by publisher]
Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation.
Acta Oncol
Sřreide AH, Edland KH, Alvestad AB, Hodne S, Sřreide K.
PMID: 41972913 [PubMed - indexed for MEDLINE]
Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective.
Biology (Basel)
Li X, Lyu H, Wu Y, Chen A, Wu G, Zhang R, Xiao S, Guo D, Zhang Q, Yan C, Tang J, Zhou C.
PMID: 41972577 [PubMed]
Immune Evasion of Helicobacter pylori and Extra-Gastric Cancer Risk.
J Gastroenterol Hepatol
Engin ED, Engin AB, Engin A.
PMID: 41972361 [PubMed - as supplied by publisher]
Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives.
Front Immunol
Zhang X, Tao X, Zhang Y, Gan G, Lv J, Zhang L, Dong D.
PMID: 41972173 [PubMed - indexed for MEDLINE]
mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting.
Mol Cell Oncol
Parganiha M, Rathored J, Sai Painkra D.
PMID: 41971684 [PubMed]
The development and validation of a machine learning algorithm for identifying lateral lymph nodes skip metastasis in papillary thyroid cancer.
Front Oncol
Cheng G, Zhang X, Cheng L, Ruan Y, Qiu Y.
PMID: 41971436 [PubMed]
Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer.
J Adv Pract Oncol
Hacker-Prietz A, Brown ME, Singer L, Narang A, Pathak P, Stricker C, Herman J.
PMID: 41971144 [PubMed]
Low-level HBV viremia independently predicts poor outcomes in patients with intermediate-to-advanced HBV-related hepatocellular carcinoma receiving systemic therapy: a multicenter retrospective study.
Ther Adv Med Oncol
Lei J, Ma H, Chen X, Lin L, Liang Z, Ou G, Jin J, Dai H, Zhang Y, Liu M, Li H, Lu Y.
PMID: 41970939 [PubMed]
Uncovered versus fully-covered self-expandable metal stents for nonpancreatic cancer: Propensity score-matched, multicenter study.
Endosc Int Open
Niiya F, Satoh T, Kaneko J, Ishikawa K, Tamai N, Yamawaki M, Noda J, Azami T, Takano Y, Nagahama M.
PMID: 41970685 [PubMed]
Articles 1 - 20 / 59705
Page 1 of 2986
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy